We are live on ! Find out more
DMKJ

David M. Knott Jr Portfolio holdings

AUM $189M
1-Year Est. Return 67.72%
This Fund
S&P 500
This Quarter Est. Return
+12.56%
1 Year Est. Return
+67.72%
3 Year Est. Return
+169.37%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$283M
AUM Growth
+$21.1M
Cap. Flow
+$9.63M
Cap. Flow %
3.41%
Top 10 Hldgs %
64.36%
Holding
124
New
11
Increased
16
Reduced
11
Closed
18

Top Buys

Rank Stock Value
1
WEST icon
Westrock Coffee
WEST
+$4.78M
2
PFE icon
Pfizer
PFE
+$4.16M
3
IRWD icon
Ironwood Pharmaceuticals
IRWD
+$3.35M
4
IMVT icon
Immunovant
IMVT
+$3.06M
5
DMRC icon
Digimarc Corp
DMRC
+$2.89M

Top Sells

Rank Stock Value
1
FTAI icon
FTAI Aviation
FTAI
+$9.6M
2
VKTX icon
Viking Therapeutics
VKTX
+$7.54M
3
ARDX icon
Ardelyx
ARDX
+$4.75M
4
MDGL icon
Madrigal Pharmaceuticals
MDGL
+$2.64M
5
CHRS icon
Coherus Oncology
CHRS
+$1.03M

Sector Composition

Rank Sector Weight
1 Healthcare 30.07%
2 Materials 23.48%
3 Miscellaneous 14.76%
4 Financials 12.15%
5 Industrials 6.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CLMT icon
1
Calumet Specialty Products
CLMT
$4.74B
$64.3M 22.73%
4,325,000
– –
APO icon
2
Apollo Global Management
APO
$77.8B
$25.3M 8.95%
225,000
– –
CLOZ icon
3
Panagram BBB-B CLO ETF
CLOZ
$798M
$19.3M 6.82%
719,368
– –
GOOG icon
4
Alphabet (Google) Class C
GOOG
$4.1T
$17.1M 6.04%
112,220
– –
FTAI icon
5
FTAI Aviation
FTAI
$20.2B
$16.8M 5.95%
250,000
-175,000
-41% -$9.6M
LGND icon
6
Ligand Pharmaceuticals
LGND
$5.76B
$8.41M 2.97%
115,000
– –
VKTX icon
7
Viking Therapeutics
VKTX
$3.93B
$8.32M 2.94%
101,436
-169,386
-63% -$7.54M
ICLO icon
8
Invesco AAA CLO Floating Rate Note ETF
ICLO
$573M
$7.86M 2.78%
307,019
– –
DCGO icon
9
DocGo
DCGO
$38.4M
$7.78M 2.75%
1,925,000
– –
PFE icon
10
Pfizer
PFE
$158B
$6.87M 2.43%
247,537
+150,000
+154% +$4.16M
JAAA icon
11
Janus Henderson AAA CLO ETF
JAAA
$30.4B
$6.35M 2.24%
125,079
+31,432
+34% +$1.59M
ARDX icon
12
Ardelyx
ARDX
$973M
$6.02M 2.13%
825,000
-555,000
-40% -$4.75M
OABI icon
13
OmniAb
OABI
$616M
$5.98M 2.12%
1,103,505
+17,000
+2% +$97.9K
AVDL
14
DELISTED
Avadel Pharmaceuticals
AVDL
$5.62M 1.99%
333,000
+81,150
+32% +$1.21M
WEST icon
15
Westrock Coffee
WEST
$766M
$4.89M 1.73%
+473,597
New +$4.78M
INZY
16
DELISTED
Inozyme Pharma
INZY
$4.32M 1.53%
564,549
– –
JPM icon
17
JPMorgan Chase
JPM
$940B
$4.2M 1.49%
20,985
– –
CPRX
18
DELISTED
Catalyst Pharmaceutical
CPRX
$2.99M 1.06%
187,852
+62,402
+50% +$940K
GSK icon
19
GSK
GSK
$97.3B
$2.79M 0.99%
65,000
– –
IMVT icon
20
Immunovant
IMVT
$8.17B
$2.76M 0.97%
85,300
+83,815
+5,644% +$3.06M
CSX icon
21
CSX Corp
CSX
$90.8B
$2.6M 0.92%
70,000
– –
LK
22
DELISTED
Luckin Coffee Inc. American Depositary Shares
LK
$2.44M 0.86%
+100,000
New +$2.44M
IRWD icon
23
Ironwood Pharmaceuticals
IRWD
$689M
$2.4M 0.85%
+276,000
New +$3.35M
CLOX icon
24
Panagram AAA CLO ETF
CLOX
$320M
$2.37M 0.84%
92,956
– –
ESGR
25
DELISTED
Enstar Group
ESGR
$2.33M 0.82%
+7,500
New +$2.15M
1
2 3 4 5

Similar funds

GFL
Granite FO LLC Bedford, New Hampshire $189M AUM 56.18% 1-Year Est. Return
SCA
Sander Capital Advisors Seattle, Washington $189M AUM 13.06% 1-Year Est. Return
FI
FWG Investments Lexington, Kentucky $189M AUM 18.47% 1-Year Est. Return
MFS
Madrid Financial Services Manhattan Beach, California $189M AUM 30.12% 1-Year Est. Return
FSBI
Fearless Solutions (Best Invest) San Antonio, Texas $189M AUM 32.69% 1-Year Est. Return
FRA
FFG Retirement Advisors Centennial, Colorado $189M AUM 16.39% 1-Year Est. Return
CAM
Councilmark Asset Management Knoxville, Tennessee $189M AUM 26.93% 1-Year Est. Return
BAG
Bauman Advisory Group Las Vegas, Nevada $189M AUM

David M. Knott Jr's Q1 2024 Portfolio in Review

As of Q1 2024, David M. Knott Jr held 124 positions worth $283M, up 8.1% from $262M the previous quarter. Its ten largest holdings account for 64% of the portfolio.

David M. Knott Jr deployed $9.63M of net new capital in Q1 2024, opening 11 new positions and adding to 16 existing holdings. Its largest new stake was Westrock Coffee: 473,597 shares worth $4.89M.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, up from 28% a quarter earlier, followed by Materials and Miscellaneous.

On the sell side, the largest reduction was FTAI Aviation, an estimated $9.6M trimmed.

  • David M. Knott Jr's largest Q1 2024 buy was Westrock Coffee: 473,597 shares worth $4.89M.
  • David M. Knott Jr added most to Pfizer in Q1 2024, an estimated $4.16M increase.
  • David M. Knott Jr's biggest Q1 2024 reduction was FTAI Aviation, cutting an estimated $9.6M.
  • David M. Knott Jr fully exited Abeona Therapeutics in Q1 2024, selling an estimated $993K.
  • David M. Knott Jr's ten largest holdings make up 64% of its $283M portfolio in Q1 2024.
  • David M. Knott Jr opened 11 new positions and closed 18 in Q1 2024.
  • David M. Knott Jr's portfolio value rose 8.1% quarter-over-quarter to $283M.

Based on David M. Knott Jr's 13F filing for Q1 2024, filed 14 May 2024.